1029 related articles for article (PubMed ID: 15109448)
41. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene.
Hes F; Zewald R; Peeters T; Sijmons R; Links T; Verheij J; Matthijs G; Leguis E; Mortier G; van der Torren K; Rosman M; Lips C; Pearson P; van der Luijt R
Hum Genet; 2000 Apr; 106(4):425-31. PubMed ID: 10830910
[TBL] [Abstract][Full Text] [Related]
42. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
[TBL] [Abstract][Full Text] [Related]
43. Molecular diagnosis of von Hippel-Lindau disease in a kindred with a predominance of familial phaeochromocytoma.
Garcia A; Matias-Guiu X; Cabezas R; Chico A; Prat J; Baiget M; De Leiva A
Clin Endocrinol (Oxf); 1997 Mar; 46(3):359-63. PubMed ID: 9156047
[TBL] [Abstract][Full Text] [Related]
44. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
[TBL] [Abstract][Full Text] [Related]
45. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
[TBL] [Abstract][Full Text] [Related]
46. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
[TBL] [Abstract][Full Text] [Related]
47. Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients.
Wu P; Zhang N; Wang X; Ning X; Li T; Bu D; Gong K
J Hum Genet; 2012 Apr; 57(4):238-43. PubMed ID: 22357542
[TBL] [Abstract][Full Text] [Related]
48. Clinical and molecular features of familial and sporadic cases of von Hippel-Lindau disease from Mexico.
Chacon-Camacho OF; Rodriguez-Dennen F; Camacho-Molina A; Rasmussen A; Alonso-Vilatela E; Zenteno JC
Clin Exp Ophthalmol; 2010 Apr; 38(3):277-83. PubMed ID: 20447124
[TBL] [Abstract][Full Text] [Related]
49. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.
Martin R; Hockey A; Walpole I; Goldblatt J
Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136
[TBL] [Abstract][Full Text] [Related]
50. Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease.
Huang Y; Zhou D; Liu J; Zhou P; Li X; Wang Z
Int J Mol Med; 2012 Jan; 29(1):47-52. PubMed ID: 21972040
[TBL] [Abstract][Full Text] [Related]
51. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
52. [Large germline deletion of the VHL gene in Chinese families with von Hippel-Lindau syndrome].
Zhang J; Chen HG; Xue W; Zhou LX; Huang YR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):539-41. PubMed ID: 19806577
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
[TBL] [Abstract][Full Text] [Related]
54. VHL P25L is not a pathogenic von Hippel-Lindau mutation: a family study.
Pettman RK; Crowley A; Riddell C; Ludman MD
Mol Diagn Ther; 2006; 10(4):239-42. PubMed ID: 16884327
[TBL] [Abstract][Full Text] [Related]
55. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
56. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.
Woodward ER; Wall K; Forsyth J; Macdonald F; Maher ER
Brain; 2007 Mar; 130(Pt 3):836-42. PubMed ID: 17264095
[TBL] [Abstract][Full Text] [Related]
57. Clinical presentation and mutation analysis of VHL disease in a large Chinese family.
Zhang Q; Li DL; Kang P; Ji N; Yang J; Liu WM; Zhang LW; Jia GJ
J Neurooncol; 2015 Nov; 125(2):369-75. PubMed ID: 26341373
[TBL] [Abstract][Full Text] [Related]
58. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
[TBL] [Abstract][Full Text] [Related]
59. Clinical presentation of Von Hippel Lindau syndrome type 2B associated with VHL p.A149S mutation in a large Turkish family.
Mete T; Berker D; Yilmaz E; Ozgen G; Yalcin Y; Tuna M; Ciliz D; Onen M; Aydin Y; Guler S
Endocrine; 2014 Feb; 45(1):128-35. PubMed ID: 23673869
[TBL] [Abstract][Full Text] [Related]
60. von Hippel-Lindau syndrome.
Chou A; Toon C; Pickett J; Gill AJ
Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
